]>
IRCT20141220020377N3 IRCT 2019-08-14 Zahedan University of Medical Sciences Melatonin in patients with Burning Mouth syndrome Comparison of the Effectiveness Of Melatonin in patients with Burning Mouth syndrome 2019-09-23 anticipated 30 Complete https://irct.ir/trial/40960 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomizd Stratified Blocking In this study, patients are randomly divided into two groups. Randomization is performed Based on the random numbers table obtained from www.randomizer.org. Even number will be allocated in intervention group and odd number in control group, Blinding description: Patients are examined by a dentistry student who is blind to the drug before treatment and VAS (Visual Analog Scale) is evaluated. 2 Burning Mouth Syndrome. Intervention 1: Intervention group: In intervention group patients will use Melatonin Tab 3 Mg (Iran Construction of A-lHavi Company) 4 times a day for 5 month. Intervention 2: Control group: In Control group patients will use PlaceboTab 4 times a day for 5 month. Yes - There is a plan to make this available What will be shared: No- There is no plan to make this available at the present time When: starting 10 months after publication To whom: Academic researchers Conditions: It is permitted to use the data in other studies with reference. Where to obtain: Nosratzehi@zaums.ac.ir How to obtain: Sending email to authors Comments:
public Dr.Tahereh Nosratzehi
Oral Medicine Department, Faculty of Dentistry, Azadegan Street, Zahedan, Iran
Zahedan Iran (Islamic Republic of) 9817699693 +98 54 3401 3041 Nosratzehi@zaums.ac.ir Zahedan University of Medical Sciences scientific Dr.Tahereh Nosratzehi
Oral Medicine Department, Faculty of Dentistry, Azadegan Street, Zahedan, Iran
Zahedan Iran (Islamic Republic of) 9817699653 +98 54 3401 3041 Nosratzahi@zaums.ac.ir Zahedan University of Medical Sciences Iran (Islamic Republic of) Burning mouth at all times Lack of Systemic Disease and chronic medication Patients over 18 years of age No use of Smoking Lack of oral lesion 18 years no limit Both Elderly people with glaucoma Those who take aspirin or heparin or warfarin Those who take acetonol and metoprolol because they reduce the effect of melatonin Patients with epilepsy T28.5 Burning Mouth Syndrome Treatment - Drugs Placebo Intervention group: In intervention group patients will use Melatonin Tab 3 Mg (Iran Construction of A-lHavi Company) 4 times a day for 5 month. Control group: In Control group patients will use PlaceboTab 4 times a day for 5 month. Level of Sensation. Timepoint: The First Visit, 8 weeks Later, 4 weeks Later,4 weeks Later, 8 weeks Later. Method of measurement: Visual Analogue Scale. Average sleep disorder. Timepoint: The First Visit, 24 weeks Later. Method of measurement: Questionnaire. Zahedan University of Medical Sciences Approved 2019-05-26 Zahedan University Of Medical Science Oral Medicine Department, Faculty Of Dentistry, Azadegan Street, Zahedan, Iran Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)